Tensions between providers and payers are increasingly spilling into the courtroom, with health systems and provider groups turning to the legal system for relief from what they say are unfair payment ...

Two North Carolina-based health systems, Atrium Health and WakeMed Health, announced plans to merge last week. As part of the proposed deal, Atrium plans to invest $2 billion into WakeMed and create 3 ...

UCB is adding a big piece to its immunology pipeline with a multi-billion dollar deal to buy Candid Therapeutics, a clinical-stage biotech company developing therapies in a promising but competitive ...

The biotech IPO window looks like it’s reopening. This past week closed with three biotech companies joining the public markets, a flurry of activity that helped make April the biggest month for ...

If you follow biosimilar headlines, you might think the market is in crisis. Stories highlight nine adalimumab biosimilars launching in just one year, and a similar pattern with the ustekinumab market ...

From how deals get sourced to how capital allocators think, generative AI is reshaping how venture capital works. For many, it’s seen as a positive, and there are truly great qualities that save real ...

Agitation is a common Alzheimer’s disease symptom, manifesting as pacing and restlessness as well as verbal and physical aggression to family members and caregivers. The drugs used to quell these ...